Deciphering the role of circulating lncRNAs: RNCR2, NEAT2, CDKN2B-AS1, and PVT1 and the possible prediction of anti-VEGF treatment outcomes in diabetic retinopathy patients.
Eman A ToraihAhmed A AbdelghanyNoha M Abd El FadealEssam Al AgeeliManal S FawzyPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2019)
Though circulating levels of the analyzed lncRNAs did not show an association with DR progression or aflibercept therapy response, the expression pattern demonstrated good diagnostic performance in differentiating DM from controls and DR.
Keyphrases
- diabetic retinopathy
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- optical coherence tomography
- peritoneal dialysis
- prognostic factors
- type diabetes
- network analysis
- computed tomography
- skeletal muscle
- binding protein
- weight loss
- mesenchymal stem cells
- transcription factor
- adipose tissue
- long non coding rna
- smoking cessation